Showing results (361-370 of 486) with videos related to
Sort By:
Pageof 49
Oncoimmunology|May 8, 2015
Trial watch: Tumor-targeting monoclonal antibodies for oncological indicationsErika Vacchelli, Jonathan Pol, Norma Bloy, et al.Oncoimmunology|August 2, 2014
Trial Watch: Toll-like receptor agonists in oncological indicationsFernando Aranda, Erika Vacchelli, Florine Obrist, et al.Autophagy|February 25, 2012
Premortem autophagy determines the immunogenicity of chemotherapy-induced cancer cell deathIsabelle Martins, Mickaël Michaud, Abdul Qader Sukkurwala, et al.Gerontology|May 3, 2008
Senescence, apoptosis or autophagy? When a damaged cell must decide its path--a mini-reviewJosé Miguel Vicencio, Lorenzo Galluzzi, Nicolas Tajeddine, et al.Autophagy|December 11, 2012
Direct interaction between STAT3 and EIF2AK2 controls fatty acid-induced autophagyMireia Niso-Santano, Shensi Shen, Sandy Adjemian, et al.Oncoimmunology|August 7, 2014
Trial Watch:: Oncolytic viruses for cancer therapyJonathan Pol, Norma Bloy, Florine Obrist, et al.Oncoimmunology|May 4, 2016
Trial Watch: Immunostimulation with Toll-like receptor agonists in cancer therapyKristina Iribarren, Norma Bloy, Aitziber Buqué, et al.Oncogenesis|September 28, 2021
The prohibitin-binding compound fluorizoline inhibits mitophagy in cancer cellsSonia Núñez-Vázquez, José Saura-Esteller, Ismael Sánchez-Vera, et al.Cell Death & Disease|May 4, 2023
Radiation therapy improves CAR T cell activity in acute lymphoblastic leukemiaMayumi Sugita, Takahiro Yamazaki, Mohammad Alhomoud, et al.Cell Cycle (Georgetown, Tex.)|July 22, 2011
p53 inhibits autophagy by interacting with the human ortholog of yeast Atg17, RB1CC1/FIP200Eugenia Morselli, Shensi Shen, Christoph Ruckenstuhl, et al.Pageof 49